Phase II Study of Gemcitabine plus Docetaxel in Advanced Pancreatic Cancer: A Hoosier Oncology Group Study

Publisher: Karger

E-ISSN: 1423-0232|65|3|218-223

ISSN: 0030-2414

Source: Oncology, Vol.65, Iss.3, 2003-12, pp. : 218-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract